Akihiro Kitadate, Hiroki Kobayashi, Yoshiaki Abe, Kentaro Narita, Daisuke Miura, Masami Takeuchi, and Kosei Matsue. 2020. “Pre-Treatment CD38-Positive Regulatory T Cells Affect the Durable Response to Daratumumab in relapsed/Refractory Multiple Myeloma Patients”. Haematologica 105 (1). Pavia, Italy, e37-e40. https://doi.org/10.3324/haematol.2019.219683.